Mirtazapine
Product Images NDC 53002-1270

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 53002-1270). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530021270)

Mirtazapine 30 mg tablets packaging label from RPK Pharmaceuticals, Inc. The label includes directions to take one tablet daily or as directed. It indicates the package contains 30 tablets in a bottle, with prescription use only. Lot numbers, expiration dates, and barcodes are also visible, along with spaces for patient and prescriber information.*

FDA Label Image

Mirtazpine Structure (Mirtazapine Str)

Chemical structure of mirtazapine, showing a multi-ring system with nitrogen atoms and a methyl group attached to a nitrogen in one of the rings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.